000 01786nam  2200349za 4500
0019.854773
003CaOODSP
00520221107155136
007cr |||||||||||
008180405s2018    onc     o    f000 0 eng d
020 |a9780660261553
040 |aCaOODSP|beng
043 |an-cn---
0861 |aH169-10/2018E-PDF
24500|aQuestions and answers |h[electronic resource] : |bprescription opioids ‐ sticker and handout requirements for pharmacists and practitioners.
24630|aPrescription opioids ‐ sticker and handout requirements for pharmacists and practitioners
260 |aOttawa : |bHealth Canada, |c2018.
300 |a8 p.
500 |aIssued also in French under title: Foire aux questions : opioïdes sur ordonnance ‐ exigences relatives à l’autocollant et à la fiche de renseignements pour les pharmaciens et les praticiens.
500 |aCover title.
500 |a"Publication date: May 2018."
500 |aIssued also in HTML format.
520 |a"This document provides guidance on the regulatory requirements specified in Part C, Division 1 of the Food and Drug Regulations regarding prescription labelling requirements for opioid drugs identified in Part A of the List of Opioids"--Introd., p. 4.
693 4|aOpioids
693 4|aPrescription drugs
693 4|aDrug labelling
7101 |aCanada. |bHealth Canada.
77508|tFoire aux questions |w(CaOODSP)9.854774
794 |tQuestions and answers : |w(CaOODSP)9.866188
85640|qPDF|s243 KB|uhttps://publications.gc.ca/collections/collection_2018/sc-hc/H169-10-2018-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/policies/opioids-questions-answers.html